CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

This study has been completed.

Study NCT00072176 Information provided by NCIC Clinical Trials Group

First Received: November 4, 2003 Last Updated: September 27, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	August 2009
Primary Completion Date:	May 2009 (Final data collection date for primary outcome measure)

Publications:

Oza AM, Elit L, Provencher D, et al.: A phase II study of temsirolimus (CCI-779) in patients with metastatic and/or locally advanced recurrent endometrial cancer previously treated with chemotherapy: NCIC CTG IND 160b. [Abstract] J Clin Oncol 26 (Suppl 15): A-5516, 2008.